Wash Legal Fdn WLF

=SEE TWO
SEE 1ST AMENDbucking for evil 7/15tag 6/16 cir ~rico gw12 tags!for origin see LEGAL FDNcomic> heuter sppac leg 1st? meese RR scaled up, franchised?=<div>---</div><div>
</div><div><div></div><div>
</div><div>ggl doc endgame:</div><div>
</div><div>
<span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">LEGAL FOUNDATIONS
<span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">PACIFIC LEGAL<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> 1973
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">memo --> The Alliance document reported that the California Chamber of Commerce picked up on <span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Powell<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> and proposed what became in 1973 the Pacific Legal Foundation, the first of eight regional litigation centers.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">[ Cases argued up the judicial ladder by radical litigators have often reached the Supreme Court. They tried unsuccessfully to roll back the Miranda rights of prisoners placed under arrest, and to limit the right of states to enforce certain environmental protections.]
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">[The Pacific Legal Foundation (PLF) was formed in California in 1973 to counter public-interest law firms and represent the interests of business and private property holders against <span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">environmental regulations.<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> PLF’s prospectus quoted the Powell memo at length. (Kim Phillips-Fein, “Invisible Hands,” p. 162).
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">When asked for his opinion of the “most critical” area of public interest law, PLF’s then-executive legal director replied, “environmental law,” citing the firm’s support for the use of DDT, the construction of a dam and reservoir project, the use of herbicides in national forests and the use of public grazing lands without environmental impact review. The early cases established a clear pattern for PLF and its followers at the Mountain States Legal Foundation and other regionally named corporate defenders. 
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Environmental cases would be a priority and the foundations’ positions in such cases would invariably be those of their business benefactors, including Monsanto, Weyerhaeuser, Gulf Oil, ARCO, Ford and other companies (Houck, "With Charity for All," pp. 1461-1462). The work of these groups also supported the Wise Use movement; radical property rights activists and corporate front groups that attacked environmental laws and regulations on behalf of landowners, ranchers and the oil industry (Helvarg, The War Against the Greens).]
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">{Soon the California Chamber of Commerce would propose what would become in 1973 the Pacific Legal Foundation, a nonprofit set up in Sacramento, California, from seed money raised by J. Simon Fluor of the Fluor Corporation [MIC]. And in 1975, the National Legal Center for the Public Interest (NLCPI) was formed "to assist in the establishment of independent regional litigation foundations dedicated to a balanced view of the role of law in achieving economic and social progress."}
<span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">WASHINGTON LEGAL FOUNDATION
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">  CIR Vioxx 38 - 60K dead;  Tozzi: CRE went after hayes; ~EPA GHG;  Starr Olsen  TORT --> defund the left (class action?)  RICO? Popeo Samp CoC<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">D'Aubusson  
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Merck called half dozen medical schools to get them to stop talking about harm of Vioxx, including Stanford; dossier on Singh
<span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">TROY<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> VIOXX: DQA, Graham, Bork<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">FDA regs 22% of economy; 
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Troy does tobacco and pharma at Wiley, then FDA (1st political vs civil service appointee; // to RR put pro-corp ppl to run regulatory agencies, but maybe they actually knew something about the industry; B43 staffed with corp PR hacks, eg Cooney CEQ Connaughton, not to mention Timberwolf, beef boy etc).  Troy not only helps industry worm in, but then lays foundation for them to continue to undermine regs after he’s left; goes back to CTT and legal foundations CIR WLF, w/ Graham [Lamar Smith builds on this DQA → IQA to gut EPA regs and stack science advisory boards, cut NOAA and NSF budget, and get “quality” research vs new incarnation of Junk science?]
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">[But the Bush administration made the chief counsel a political appointee for the first time since the 1980s, easing out civil-servant Porter and empowering Troy...Appointed in August, 2001, Troy had vast authority. With no FDA commissioner until November 2002, Troy reigned for more than a year as top administrator in an agency that regulates 22 percent of the U.S. economy.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">"He sent a signal to companies that if you want to deal with the FDA on a number of issues, he's the man to see," said a senior FDA official.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap" style="background-color: rgb(255, 153, 0);">In three years, Troy has held 129 meetings with lobbyists and others with issues before the FDA.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Mark McClellan, commissioner from October 2002 to March 2004, held 30 such meetings, FDA records show.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">From 1998 to 2001, Troy's predecessor, Margaret Porter, held one meeting.]
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">{August 2001: Bush Appoints Daniel E. Troy as the FDA’s chief counsel<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> <span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">President Bush appoints Daniel E. Troy as the FDA’s chief counsel. [FINANCIAL TIMES, 8/14/2001] Before taking the position, Troy was a partner at the law firm Wiley Rein & Fielding, where he sued the FDA several times on behalf of drug companies, including pharmaceutical giant Pfizer. He has repeatedly argued that the agency has only limited authority to regulate drug companies. Troy is mostly known for his involvement in the landmark Supreme Court case that ruled the FDA does not have the authority to regulate tobacco. [BOSTON GLOBE, 12/22/2002; DENVER POST, 5/23/2004] }
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap"> Troy "was a symbol of what is rotten at the FDA: the pharmaceutical industry's influence has ensured that business interests take precedence over public safety.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">[In a dramatic legal novelty, the FDA has intervened for manufacturers in lawsuits, urging courts to dismiss damages claims against them. FDA briefs have helped the world's two largest drug companies win product-liability cases.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">The FDA says courts are not equipped to judge a product's safety. On regulation, officials say their position reflects court rulings that warn about restricting commercial speech. Allowing inconclusive health claims on food labels such as walnuts gives consumers more information, the agency says...A Queens-born Columbia Law School standout, Troy, 44, came to the FDA primed for activism: Clerk for conservative icon Robert Bork; partner at blue-chip Wiley, Rein & Fielding[acta anna neal?]; scholar at the pro-business American Enterprise Institute; litigant for the anti-regulatory Washington Legal Foundation.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap" style="background-color: rgb(255, 153, 0);">Representing a tobacco company against the FDA in the late 1990s, Troy helped win a landmark Supreme Court ruling blocking the agency's attempt to regulate tobacco products.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Litigating for the legal foundation, which drug-company foundations help fund, Troy challenged the FDA's restrictions on promoting drugs for uses the FDA has not approved.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">The policy, Troy wrote in 1999, reflects "an overzealous FDA."
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Appointed in August, 2001, Troy had vast authority. With no FDA commissioner until November 2002, Troy reigned for more than a year as top administrator in an agency that regulates 22 percent of the U.S. economy.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">"He sent a signal to companies that if you want to deal with the FDA on a number of issues, he's the man to see," said a senior FDA official.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">In three years, Troy has held 129 meetings with lobbyists and others with issues before the FDA.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">Mark McClellan, commissioner from October 2002 to March 2004, held 30 such meetings, FDA records show.
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">From 1998 to 2001, Troy's predecessor, Margaret Porter, held one meeting..'] th frank
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">" <span times="Times" new="New" roman="Roman" font-weight="font-weight" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">WLF <span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">is to the first amendment what the NRA is to the second amendment. That is, every argument by WLF begins and ends with the first amendment as it applies to a special interest group -- i.e., businesses like the pharmaceutical industry. "
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">{ Expanding corporate influence over the U.S. educational system was one of the crucial themes of Powell's memo to the U.S. Chamber of Commerce. Corporate power in society gained longevity from influencing the opinions of educated young adults about to enter the workforce and helped reshape institutions of higher learning to prioritize commercial interests.}
<span times="Times" new="New" roman="Roman" font-variant-numeric="font-variant-numeric" normal="normal" font-variant-east-asian="font-variant-east-asian" vertical-align="vertical-align" baseline="baseline" white-space="white-space" pre-wrap="pre-wrap">---<div></div></div></div>==<a href="https://nebula.wsimg.com/aad41051818e710eb5d3242de005e126?AccessKeyId=39A2DC689E4CA87C906D&disposition=0&alloworigin=1">https://nebula.wsimg.com/aad41051818e710eb5d3242de005e126?AccessKeyId=39A2DC689E4CA87C906D&disposition=0&alloworigin=1</a>inside erpa.comFriday, February 20, 2015

KEY ISSUES:

Boilers | Tier 3 | EDSP | Climate Rules

DAILY NEWS EPA Critics Float New Strategy To Challenge Agency Rules Using Data

Law Posted: February 19, 2015 Backed by former White House regulatory review officials, a free-market advocate is proposing a new legal theory

to allow states and private companies to sue EPA based on alleged violations of the Information Quality Act (IQA)

in the development of a host of rules, dodging the long-standing holding that IQA violations are immune from

judicial review. Federal courts have long held that private plaintiffs lack standing to challenge agency actions under the IQA, finding

that the law lacks an explicit right of action and that suits brought under the Administrative Procedure Act (APA) are

not reviewable because challenged agency actions are not “final.”

But in a February white paper [http://www.wlf.org/upload/legalstudies/workingpaper/2015Kogan.pdf] published by

the Washington Legal Foundation (WLF), Lawrence A. Kogan, a trade lawyer and free-market advocate, suggests

that states and private plaintiffs could have standing to challenge EPA's greenhouse gas (GHG) endangerment

finding on the theory that the plaintiffs have a right to be free from regulations that are founded on flawed science

that contravenes the law's intent.

“The contemplated cause of action is based on the theory that Congress intended that the IQA . . . protect

thenegative right of a designated class of persons not to be burdened, financially or otherwise, by poor quality

science that agencies disseminate in support of major regulations,” Kogan says in the paper, “Revitalizing The

Information Quality Act As A Procedural Cure For Unsound Regulatory Science: A Greenhouse Gas Rulemaking

Case Study.” He suggests that a challenge to EPA's 2009 finding that GHGs endanger public welfare -- the basis for EPA's

climate regulatory program -- could provide a venue for plaintiffs to test the theory.

“EPA’s 2009 GHG Endangerment Findings and the decision-making process that led to those Findings, offer an

ideal case study in how the IQA applies in the rulemaking context and how agencies contravene the law. . . . Such

final agency action potentially gives rise to legal challenges of EPA’s failure to comply with the IQA’s peer-review

standards,” the paper says.

If courts accept Kogan's reasoning it would open the door for EPA's opponents to allege IQA violations in

challenges against a broad array of other rules, including still-pending actions and some recently finalized

regulations.  
For example, Jim Tozzi -- formerly a high-ranking official in the White House Office of Management

and Budget -- says in an introduction to the paper that Kogan's theory could also be used to challenge EPA's

controversial new source performance standards (NSPS) for GHG emissions limits from power plants when the final

versions of that rule is released later this year.

“Another possible target of the type of IQA challenge [Kogan] proposes would be against EPA’s failure to conduct a

peer review of 'highly influential scientific information' in its determination that carbon storage and sequestration is

a viable technology -- the central component of its proposed rule to control emissions from new gas-fired power

plants,” Tozzi writes in the introduction.

IQA Challenges

Later in the white paper, Kogan says that a successful climate IQA suit would pave the way for further challenges to

EPA actions including the pending rule to define which waters are subject to the Clean Water Act; the social cost of

carbon, which underlies many GHG standards; the proposed national ambient air quality standard for ozone; EPA's

study on the human-health and environmental impacts of hydraulic fracturing; review of the Keystone XL pipeline's

environmental impacts; joint EPA and National Oceanic and Atmospheric Administration disapproval of states'

coastal nonpoint source pollution control programs; and the Fish and Wildlife Service’s endangered species

designations.

Tozzi in his introduction to the paper says that if courts reject Kogan's legal arguments, the executive branch -- in

particular OMB -- could step in to conduct more robust oversight of agencies' research and response to petitions

under the IQA. And he also suggests that if the effort fails, “then it is time for the Congress to pass legislation which

declares that the [IQA] to be judicially reviewable.”The IQA -- also known as the Data Quality Act -- generally requires agencies to ensure that scientific and other data

used to develop policy stances are objective, reproducible and peer-reviewed. While the law requires agencies to

accept and respond to petitions to correct allegedly flawed data used in rulemakings and other decisions, key federal

courts have so far held that agency responses to IQA petitions are not final actions and therefore not judicially

reviewable, eliminating an enforcement mechanism for private parties to pursue challenges on the merits if agencies

deny their petitions.

Despite the legal hurdles, EPA critics have continued to file IQA petitions seeking corrections of agency

determinations. For example, conservative groups have long alleged that EPA ignored IQA requirements in its 2009

endangerment finding -- which was a prerequisite for EPA regulation of vehicle GHG emissions and other sources

after the Supreme Court ruled in Massachusetts v. EPA that GHGs are “pollutants” and subject to Clean Air Act

regulation.

The endangerment finding has already survived one major court challenge, Coalition for Responsible Regulation v.

EPA, in which the U.S. Court of Appeals for the District of Columbia Circuit upheld the agency's determination and

the Supreme Court declined a petition for review.

But the WLF paper argues that the finding could be vulnerable to a second challenge, largely based on the IQA, even

though courts do not allow suits directly challenging EPA's responses to IQA petitions.

Kogan says that even though the law does not allow direct suits, it can be read as creating a right “to be unburdened

by improperly peer-reviewed information” -- and that opponents of EPA rules could invoke that right when suing

under the APA, which allows challenges to any “final agency action” that is allegedly “arbitrary, capricious, an

abuse of discretion or otherwise not in accordance with law.”

Final Action...==cf troy FDA watchhttp://www.wlf.org/upload/062105RS.pdfFOR IMMEDIATE RELEASE June 21, 2005

WLF LAUNCHES “FDA/DDMAC WATCH”

WLF Launches New Program To Scrutinize FDA Advertising Regulation

The Washington Legal Foundation (WLF) today announced a new program to monitor

federal regulation of prescription drug advertising. WLF has determined that the Food and

Drug Administration (FDA), acting through its Division of Drug Marketing, Advertising, and

Communications (DDMAC), has been using letters to industry to advance questionable legal

theories and request remedial actions that the agency could not require under the law.

Under the program (to be known as "DDMAC Watch"), when DDMAC sends a letter to

a drug company employing theories that are legally deficient or ill-advised, WLF will send a

letter of our own back to DDMAC identifying the specific ways in which this is so. Our letter

will also be publicly available. In addition to this rapid response component, WLF will

analyze DDMAC warning and untitled letters to detect patterns in its oversight of drug

promotion that raise legal or other issues. These analyses will also be made publicly available

on a periodic basis. WLF inaugurated its program today by formally requesting DDMAC to

withdraw a letter it sent to Eli Lilly and Co. regarding promotion of one of Lilly's drugs.

“Consumers are active partners in their own health care, and the pace of medical progress

is rapid and hastening. The public must have access to the latest information on advances in

patient care. Pharmaceutical companies are at the leading edge of medical advances, and are

ideally situated to disseminate high-quality scientific information to the patients and

prescribers who need it,” said WLF Chief Counsel Richard Samp. “DDMAC should start

providing concrete guidance to industry to help them fulfill this objective and stop playing

‘gotcha’ with drug companies,” Samp said.

In support of its claim that DDMAC acts outside its legal authority, WLF pointed to the

lack of any statutory basis for the warning and untitled letters that DDMAC routinely sends to

drug companies alleging legal violations. Warning and untitled letters were invented by FDA

in the 1970s as a way of acting against a company without having to go to court. With no

judicial safeguards to protect against abuses, FDA often uses warning and untitled letters to

allege legal theories that are unsupported by the law and demand remedial actions that it lacks

legal authority to require. DDMAC is among the worst offenders, showing continued

disregard for the First Amendment by alleging that materials are misleading with no evidence

of how consumers understand them, requiring greater disclosure of risk information in ads

than the law requires, and “requesting” corrective advertising in every warning letter even

though this is not available under the law....==<a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation">http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation</a>

===exxon?the State of Ohio, Peter F. Kilmartin, Attorney General,

Office of the Attorney General for the State of Rhode Island,

Marty J. Jackley, Attorney General, Office of the Attorney

General for the State of South Dakota, Mark L. Shurtleff,

Attorney General, Office of the Attorney General for the State

of Utah, William H. Sorrell, Attorney General, Office of the

Attorney General for the State of Vermont, Vincent F.

Frazier, Attorney General, Office of the Attorney General for

the Virgin Islands, Robert M. McKenna, Attorney General,

Office of the Attorney General for the State of Washington,

and Darrell V. McGraw, Jr., Attorney General, Office of the

Attorney General for the State of West Virginia, were on the

brief for amici curiae States.

Noel J. Francisco argued the cause for appellees. With

him on the briefs were Warren D. Postman, Philip J. Perry,

Jonathan D. Hacker, Floyd Abrams, Joel Kurtzberg, and

Patricia A. Barald.

Bert W. Rein, John E. Barry, Robin S. Conrad, Kathryn

Comerford Todd, and Sheldon Gilbert were on the brief for

amicus curiae Chamber of Commerce of the United States of

America in support of appellees. Daniel J. Popeo, Cory L. Andrews, and Richard A. Samp

were on the brief for amicus curiae Washington Legal

Foundation.

Robert Corn-Revere and Ronald G. London were on the

brief for amici curiae Associationvioxxpharma mkt blog john mack<div>
</div><div><h2 class="date-header" style="margin: 10px 0px 0px; color: rgb(119, 119, 119);">Tuesday, June 28, 2005</h2><div class="date-posts"><div class="post-outer"><div class="post" style="margin: 0px 0px 30px;"><a id="111991625613066566" name="111991625613066566" style="color: rgb(158, 82, 5);" /><h3 class="post-title" style="margin: 0px; color: rgb(14, 114, 4); letter-spacing: -1px;"><a href="http://pharmamkting.blogspot.com/2005/06/wlf-watches-fda-watching-drug-ads.html" style="color: rgb(14, 114, 4); background-color: rgb(255, 255, 255);">WLF Watches FDA Watching Drug Ads</a></h3><div class="post-header-line-1"><div class="post-body">The Washington Legal Foundation (WLF), a conservative watchdog group funded by businesses (including drug companies), last week launched the "FDA/DDMAC Watch" program to "scrutinize" FDA advertising regulations. DDMAC is the FDA's Division of Drug Marketing, Advertising, and Communications, which oversees drug ads.

DDMAC Watch's first action challenged an FDA warning letter regarding a TV ad for Eli Lilly & Co.'s adult ADD therapy, Strattera (see "<a href="http://www.brandweek.com/brandweek/headlines/article_display.jsp?vnu_content_id=1000969064" style="color: rgb(158, 82, 5); background-color: rgb(255, 255, 255);">Watchdog Group Blasts FDA</a>").
 <blockquote>According to the WLF, the FDA is acting “"outside its legal authority"” when its writes such letters, and shows "“disregard for the First Amendment by alleging that materials are misleading with no evidence of how consumers understand them." ” (See the <a href="http://www.wlf.org/upload/DDMACWatch.pdf" style="color: rgb(158, 82, 5); background-color: rgb(255, 255, 255);">WLF Letter to DDMAC</a>).

In short, the Washington Legal Foundation claims, the FDA "“invented" much of its power to police drug advertising. ("<a href="http://www.brandweek.com/brandweek/headlines/article_display.jsp?vnu_content_id=1000969064" style="color: rgb(158, 82, 5); background-color: rgb(255, 255, 255);">Watchdog Group Blasts FDA</a>").</blockquote>WLF is to the first amendment what the NRA is to the second amendment. That is, every argument by WLF begins and ends with the first amendment as it applies to a special interest group -- i.e., businesses like the pharmaceutical industry.

The House(s) That Troy Built</div><div class="post-body">
What's really interesting, however, are the ties that bind WLF, FDA, and the Pharma industry.

One of the main ties is Daniel E. Troy, former chief counsel to the FDA who joined WLF's board of directors just 4 days before the DDMAC Watch letter. According to the WLF Web site, Troy was "the first appointee to the Food and Drug Administration made by President George W. Bush."
<blockquote>"Troy managed to restrict FDA's ability to use its statutes creatively, and this in turn deterred mid-level managers from advocating new approaches to emerging scientific issues, leaving the agency looking - and feeling - weak." (See "<a href="http://www.ahrp.org/infomail/04/11/18.php" style="color: rgb(158, 82, 5);">FDAers Think Troy Weakened Them, Worry About Masoudi</a>").</blockquote>Before his stint at the FDA, Troy repeatedly sued the FDA. He argued that the FDA had only limited ability to regulate drug companies. Troy filed those suits through --- you guessed it -- the WLF! He also did legal work for Pfizer. Oh well, just another case of "What goes around, comes around."

What About Those Warning Letters?
The WLF criticism of the Strattera warning letter, which I will get to in a moment, comes at a time when the FDA is sharply increasing the number of warning letters sent to pharmaceutical companies.

The FDA issues two types of letters: untitled letters or Notices of Violation and warning letters. The warning letter goes to the CEO and essentially says "we think you have really screwed up and in a way that we think is important to the public health and we expect you to put out some kind of additional information to correct the misinformation you sent." (I quote here John Kamp, Executive Director, Coalition for Healthcare Communication. Kamp was speaking at a CME conference in Princeton, NJ.)

An untitled letter is sent to the head of marketing and says "we think you have a problem, let's sit down and work something out." This type of letter is much less serious and effective than a warning letter. In fact, I've heard it said that untitled letters are considered rites of passage by pharma product managers, who frame them and hang them on their office walls. That's what I've heard some people say.

According to the Philadelphia Inquirer ("<a href="http://www.drugawareness.org/Archives/1stQtr_2004/record0058.html" style="color: rgb(158, 82, 5);">Deluge of drug ads has FDA struggling to stop the hype</a>"):
<blockquote>In January 2002, the Office of the FDA Chief Legal Counsel, Daniel Troy, began reviewing the evidence behind all proposed enforcement letters with an eye toward scuttling any that might not hold up in court. Claude Allen, the deputy secretary of the Health and Human Services Department, the FDA's parent agency, ordered the change in policy.</blockquote>Troy effectively hobbled the issuance of warning letters by the FDA.
<blockquote>An October 2002 study by the General Accounting Office, the investigative arm of Congress, said that, before Troy's reviews began, FDA notices went out within days after a problem ad was spotted. Under the new policy, clearing the letters took 13 to 78 days, the report said. "Some regulatory letters may not be issued until after the advertising campaign has run its course," the GAO found. (Phila Inquirer)</blockquote>While the number of total enforcement letters sent by the FDA has hovered around 23-25 in the last three years, the number of warning letters increased dramatically in 2004 (before Troy left the FDA but during the VIOXX debacle). In that year the FDA issued 12 warning letters compared to 5 in 2003 and 1 in 2002. 2005 promises to be a record year -- already nine warning letters have been issued.

The FDA may be getting the impression that the drug industry is not listening. According to Kamp, "DDMAC is saying the same things over and over again [in warning letters], but the industry is just not getting it. FDA is turning up the heat. How much higher, might I add, does it have to get before we start paying attention?"

If the WLF represents the pharma industry -- and with Troy involved it's hard to dispute that it does -- then the industry is paying attention, but responding by criticizing the FDA. There has been some more positive response as well. Recent DTC policy changes by J&J and BMS come to mind (see "<a href="http://pharmamkting.blogspot.com/2005/03/dtc-straight-talk.html" style="color: rgb(158, 82, 5);">DTC Straight Talk</a>" and "<a href="http://pharmamkting.blogspot.com/2005/06/new-dtc-principles-emerging.html" style="color: rgb(158, 82, 5);">New DTC Principles Emerging</a>").

So What's the Beef With the Strattera TV Ad?</div><div class="post-body">
The FDA had asked Lilly on June 14 to pull its Strattera TV ad on the grounds that the flashy graphics made the warnings on side effects too difficult for consumers to comprehend (see <a href="http://www.wlf.org/upload/strattera.pdf" style="color: rgb(158, 82, 5);">warning letter</a> and "<a href="http://www.brandweek.com/brandweek/headlines/article_display.jsp?vnu_content_id=1000969064" style="color: rgb(158, 82, 5);">Watchdog Group Blasts FDA</a>").

WLF had this to say:
<blockquote>"DDMAC cites no evidence demonstrating that consumers cannot process the information presented in the advertisement. In fact, the TV advertisement conveys its message regarding attention deficit disorder so many times that it is incomprehensible that consumers would miss it. The sole source of authority for DDMAC's allegations against Lilly is the individual judgment of the DDMAC reviewer who signed the letter."
</blockquote>I don't recall seeing the ad myself, but the FDA presented <a href="http://www.fda.gov/cder/warn/2005/Strattera1.jpg" style="color: rgb(158, 82, 5);">promotional material</a>, submitted by Lilly, which included screen shots from the ad. It looks distracting to me. I don't think you have to do a scientific study to tell whether or not an ad is effectively presenting labeling information. To suggest that "evidence" be produced is merely a ploy to delay the process so the ad can run it's course.

The problem is that the review by the FDA happens after the ad is already produced and running. It would be better, as proposed by BMS, that DTC ads be submitted to the FDA for approval BEFORE they run (see "<a href="http://pharmamkting.blogspot.com/2005/06/new-dtc-principles-emerging.html" style="color: rgb(158, 82, 5);">New DTC Principles Emerging</a>").

Guidance Needed
There is at least one point made by the WLF that I can agree with. It has to do witrh guidance from the FDA regarding TV DTC ads for Rx drugs:
<blockquote>"DDMAC should start providing concrete guidance to industry to help them fulfill this objective and stop playing 'gotcha' with drug companies," said WLF Chief Counsel Richard Samp.
</blockquote>Maybe Samp has a point. While the FDA has issued guidance regarding print DTC ads (see "<a href="http://pharmamkting.blogspot.com/2005/06/future-of-drug-print-ads.html" style="color: rgb(158, 82, 5);">Future of Drug Print Ads</a>"), it hasn't done the same for TV DTC ads. Perhaps that will come sooner than Samp would like.</div></div></div></div></div></div>=

We honor former WLF Board members who have chosen to pursue public service:

The Honorable Susan G. Braden

U.S. Court of Federal Claims Judge

The Honorable M. Jane Brady

Judge, Superior Court of the State of Delaware

The Honorable Richard J. Leon

U.S. District Court Judge

The Honorable Bill Pryor

Judge, U.S. Court of Appeals for the Eleventh Circuit

---

<table cellpadding="0" cellspacing="0" border="0" style="color: rgb(59, 49, 40); line-height: 15.1999998092651px; background-color: rgb(255, 255, 255);"><tbody><tr><td>CHAIRMAN OF THE BOARD

<a href="http://www.klgates.com/professionals/detail.aspx?professional=930" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Dick Thornburgh</a>

Of Counsel

K&L Gates LLP

Washington, DC

CHAIRMEN EMERITUS

<a href="http://www.americangaming.org/About/bios/bio_fahrenkopf.cfm" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Frank J. Fahrenkopf, Jr., Esq.</a>

<a href="http://www.steptoe.com/professionals-545.html" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Richard K. Willard, Esq.</a>

Partner

Steptoe & Johnson LLP

Washington, DC

BOARD MEMBERS

Joseph A.  Artabane, Esq.

Artabane & Belden, P.C.

<a href="http://law.lawnet.fiu.edu/index.php?option=com_content&task=view&id=121&Itemid=277" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor Thomas E. Baker</a>

Professor of Law

Florida International University College of Law

<a href="http://www.shb.com/attorney_detail.aspx?id=13" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Mark A. Behrens</a> asbestos yup sep node

Partner

Shook, Hardy & Bacon LLP

Washington, DC

<a href="http://www.pattonboggs.com/tboggs/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Thomas Hale Boggs, Jr., Esq.</a>

Partner

Patton Boggs LLP

Washington, DC

<a href="http://www.swlaw.com/attorneys/gregory_brower" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Gregory A. Brower</a>

Partner

Snell & Wilmer

Las Vegas and Reno, NV

<a href="http://www.reedsmith.com/ourattorneys/viewAttorney.cfm?itemid=9061" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Michael K. Brown, Esq.</a>

Partner

Reed Smith

Los Angeles, CA

<a href="http://www.venable.com/james-h-burnley/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable James H. Burnley, IV</a>

Partner

Venable LLP

Washington, DC

<a href="http://www.wileyrein.com/professionals.cfm?sp=bio&id=1576" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Ralph J. Caccia, Esq.</a>

Partner

Wiley Rein LLP

Washington, DC

<a href="http://www.jonesday.com/macarvin/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Michael A. Carvin, Esq.</a>

Partner

Jones Day

Washington, DC

<a href="http://www.cooperkirk.com/lawyer.php?lawyer_id=3" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Charles Cooper, Esq.</a>

Founding Partner

Cooper & Kirk PLLC

Washington, DC

<a href="http://www.digenovatoensing.com/attorneybiosjd.htm" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Joseph E. diGenova, Esq.</a>

Founding Partner

diGenova & Toensing

Washington, DC

<a href="http://www.law.georgetown.edu/curriculum/tab_faculty.cfm?Status=Faculty&Detail=204" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor Viet D. Dinh</a>

Professor of Law

Georgetown University Law Center

Washington, DC

<a href="http://businessroundtable.org/news-center/business-roundtable-names-john-engler-president1/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable John Engler</a>

President

The Business Roundtable

<a href="http://www.ofwlaw.com/Bio/RichardFrank.asp" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Richard L. Frank</a>

Olsson Frank Weeda Terman Bode Matz PC

Washington, D.C.

<a href="http://www.furchtgott-roth.com/aboutus.php?PHPSESSID=1ffa12cf25a6717d351bc76d5b093a3d" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Harold Furchtgott-Roth</a>

President

Furchtgott-Roth Economic Enterprises

<a href="http://www.mayerbrownrowe.com/lawyers/profile.asp?hubbardid=G582012296&lawyer_name=Geller%2C+Kenneth" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Kenneth S. Geller, Esq.</a>

Partner, Managing Partner

Mayer Brown LLP

Washington, DC

<a href="http://www.ebglaw.com/atty_bio_29.htm" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Stuart M. Gerson, Esq.</a>

Member of the Firm

Epstein Becker & Green, P.C.

Washington, DC; New York, NY

<a href="http://ghrfirm.com/attorney-profiles/thomas-goldstein" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Thomas C. Goldstein, Esq.</a>

Partner

Goldstein & Russell, P.C.

Washington, DC

<a href="http://www.whitecase.com/egrannon/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Eric Grannon, Esq.</a>

Partner

White & Case

Washington, DC

<a href="http://indylaw.indiana.edu/people/profile.cfm?EmpNum=197" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor William F. Harvey</a>

Carl M. Gray Professor of Law Emeritus

Indiana University School of Law, Indianapolis

<a href="http://www.law.uoregon.edu/faculty/mholland/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor Maurice J. Holland</a>

Professor Emeritus

University of Oregon, School of Law

<a href="http://www.sidley.com/coleen-klasmeier/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Coleen Klasmeier</a>

Partner

Sidley Austin LLP

Washington, D.C.

<a href="http://www.mayerbrownrowe.com/lawyers/profile.asp?hubbardid=L454506994&lawyer_name=Lacovara%2C+Phili" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Philip A. Lacovara, Esq.</a>

Senior Counsel

Mayer Brown LLP

New York, NY

<a href="http://www.lexpertresearch.com/founder.html" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Susan W. Liebeler, Esq.</a>

President

Lexpert Research Services

Los Angeles, CA

Daniel M. Mandil

Senior Vice President and Deputy General Counsel

Viacom

New York, New York

<a href="http://www.weil.com/arvinmaskin/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Arvin Maskin, Esq.</a>

Litigation Partner

Weil, Gotshal & Manges LLP

New York, NY

The Honorable Robert F. McDonnell

Governor

Commonwealth of Virginia

<a href="http://www.orrick.com/Lawyers/Robert-McKenna/Pages/default.aspx" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Rob McKenna</a>

Attorney General

Orrick, Herrington & Sutcliffe LLP

Seattle, Washington

<a href="http://www.dlapiper.com/john_merrigan/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">John A. Merrigan, Esq.</a>

DLA Piper

<a href="http://www.law.virginia.edu/lawweb/faculty.nsf/23dd47a7df1a19b8852566d100206b3d/c5cf2d983d4a579e85256c690060468c?OpenDocument" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor John Norton Moore</a>

Walter L. Brown Professor of Law

University of Virginia, School of Law

<a href="http://www.oblon.com/people/index.php?id=48" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Gerald J. Mossinghoff</a>

Senior Counsel

Oblon, Spivak, McClelland, Maier & Neustadt

Alexandria, VA

<a href="http://www.jonesday.com/gdnager/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Glen D. Nager, Esq.</a>

Partner

Jones Day

Washington, DC

<a href="http://www.gibsondunn.com/Lawyers/tolson" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Theodore B. Olson</a>

Partner

Gibson, Dunn & Crutcher LLP

Washington, DC

<a href="http://www.law.northwestern.edu/faculty/profiles/StephenPresser/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor Stephen B. Presser</a>

Raoul Berger Professor of Legal History

Northwestern University, School of Law

<a href="http://www.law.yale.edu/faculty/GPriest.htm" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Professor George L. Priest</a>

Professor of Law & Economics

Yale University Law School

<a href="http://www.cadwalader.com/Attorney/Charles_F.%28Rick%29_Rule/1396" target="blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Charles F. (Rick) Rule, Esq.</a>

Partner

Cadwalader Wickersham & Taft

Washington, DC

<a href="http://www.baylor.edu/president/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Kenneth W. Starr</a>

President

Baylor University

Waco, Texas

<a href="http://www.treasurer.org/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable Don Stenberg</a>

Treasurer

State of Nebraska

<a href="http://www.akingump.com/rstrauss/" target="blank" style="text-decoration: none; background-color: rgb(255, 255, 102);">Ambassador</a><a href="http://www.akingump.com/rstrauss/" target="blank" style="text-decoration: none; color: rgb(0, 51, 204); background-color: rgb(255, 255, 102);"> Robert S. Strauss</a>

Partner

Akin Gump Strauss Hauer & Feld LLP

Washington, DC

<a href="http://www.ago.state.co.us/about_ag.cfmcpyID=17.html" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable John W. Suthers</a>

Attorney General

State of Colorado

<a href="http://www.morganlewis.com/index.cfm/personID/e5c8c843-0782-4f90-8b2e-f33d47c20dee/fromSearch/1/fuseaction/people.viewBio" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">George J. Terwilliger III, Esq.</a>

Partner

Morgan, Lewis & Bockius LLP

Washington, DC

Daniel E. Troy

Senior Vice President and General Counsel

GlaxoSmithKline

<a href="http://www.mwe.com/index.cfm/fuseaction/bios.detail/object_id/baf2aec0-787a-435b-9403-5f634a71f7b9.cfm" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">The Honorable William F. Weld</a>

Partner

McDermott Will & Emery LLP

New York, NY

<a href="http://www.gtlaw.com/People/JoeDWhitley" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Joe D. Whitley, Esq.</a>

Shareholder

Greenberg Traurig, LLP

Washington, DC; Atlanta, GA

<a href="http://www.bryancave.com/waynewithers/" target="_blank" style=" text-decoration: none; color: rgb(0, 51, 204);">Wayne Withers</a>

Of Counsel

Bryan Cave LLP

St. Louis, MO

</td></tr></tbody></table>

==popeo?

Founder, Chairman and General Counsel, Washington Legal Foundation

Former Trustee, Captial Research Center

Former Nixon and Ford administration staffer, according to PR Watch http://www.prwatch.org/taxonomy/term/105?from=60 

Founded WLF in 1977 after leaving his post as an attorney with the Department of Justice

J.D. Georgetown Law School

<h3 style="padding: 10px; margin: 0px; color: rgb(102, 102, 102); text-transform: uppercase; background-color: rgb(204, 204, 204);">KEY DEEDS</h3>

24 January, 2007

Authored "The State of Our Energy is Dangerous," an editorial piece published in the Washington DC Examiner on January 24, 2007 asserting that "Environmentalists who claim that burning any fossil fuel emits carbon dioxide and contributes to global warming nevertheless oppose the one energy source that produces zero carbon dioxide - safe and reliable nuclear energy."

Source: <a href="http://www.exxonsecrets.org/html/personfactsheet.php?id=1266#src2" style=" color: rgb(153, 0, 0); text-decoration: none;">The Examiner (Washington DC) 2007</a>

29 January, 2007

Authored "Surrendering Energy Independence," a 1/29/07 paid advertorial in the New York Times which stated: "Yet environmentalists who claim that burning any fossil fuel contributes to global warming even oppose using the one dependable energy source that produces zero carbon dioxide - safe and reliable nuclear energy."

Source: <a href="http://www.exxonsecrets.org/html/personfactsheet.php?id=1266#src3" style=" color: rgb(153, 0, 0); text-decoration: none;">Washington Legal Foundation 2007 (PDF)</a>

<h3 style="padding: 10px; margin: 0px; color: rgb(102, 102, 102); text-transform: uppercase; background-color: rgb(204, 204, 204);">DEEDS</h3>

24 July, 2006

Authored "Had Enough?," an editorial piece criticizing "decades of obstructionist lawsuits brought by environmental activists" and adding that "uncompromising elites still obsess about the habitats of plant and insect subspecies."

Source: <a href="http://www.exxonsecrets.org/html/personfactsheet.php?id=1266#src1" style=" color: rgb(153, 0, 0); text-decoration: none;">WLF Website (2006)</a>

9 July, 2001

Authored "Targeting American Prosperity," a 7/9/01 paid advertorial in the New York Times arguing that "The world may be moving towards just such a conflict, as envious foreign competitors and international bureaucrats, allied with antibusiness activists, are attempting to handicap the U.S. economy under the guise of preventing "global warming." Their weapon of choice a deeply flawed international treaty imposing radical limits on energy use and production will turn American consumers and businesses into casualties of economic warfare." www.wlf.org/upload/7-9-01%20NYT.pdf

Source: <a href="http://www.exxonsecrets.org/html/personfactsheet.php?id=1266#src4" style=" color: rgb(153, 0, 0); text-decoration: none;">New York Times 2001 (PDF)</a>

<h3 style="padding: 10px; margin: 0px; color: rgb(102, 102, 102); text-transform: uppercase; background-color: rgb(204, 204, 204);">ORGANIZATIONS</h3>

<a href="http://www.exxonsecrets.org/html/orgfactsheet.php?id=69" style=" color: rgb(153, 0, 0); text-decoration: none;">Washington Legal Foundation</a>

Source: <a href="http://www.exxonsecrets.org/html/personfactsheet.php?id=1266#src0" style=" color: rgb(153, 0, 0); text-decoration: none;">Washington Legal Foundation Website (2006)</a>

<h3 style="padding: 10px; margin: 0px; color: rgb(102, 102, 102); text-transform: uppercase; background-color: rgb(204, 204, 204);">SOURCES</h3>

<a id="src" name="src" style=" color: rgb(153, 0, 0);"> </a><a id="src0" name="src0" style=" color: rgb(153, 0, 0);">Washington Legal Foundation Website (2006)

</a><a href="http://www.wlf.org/" style=" color: rgb(153, 0, 0); text-decoration: none;">http://www.wlf.org</a>

<a id="src1" name="src1" style=" color: rgb(153, 0, 0);">WLF Website (2006)

</a><a href="http://www.wlf.org/upload/072106IAF.pdf" style=" color: rgb(153, 0, 0); text-decoration: none;">http://www.wlf.org/upload/072106IAF.pdf</a>

<a id="src2" name="src2" style=" color: rgb(153, 0, 0);">The Examiner (Washington DC) 2007

</a><a href="http://www.examiner.com/a-525494_{Daniel_J}_Popeo_{The_state_of_our_energy_is_dangerous.html}" style=" color: rgb(153, 0, 0); text-decoration: none;">http://www.examiner.com/a-525494_{Daniel_J}_Popeo_{The_state_of_our_energy_is_dangerous.html</a>}

<a id="src3" name="src3" style=" color: rgb(153, 0, 0);">Washington Legal Foundation 2007 (PDF)

</a><a href="http://www.wlf.org/upload/1-29-072.pdf" style=" color: rgb(153, 0, 0); text-decoration: none;">http://www.wlf.org/upload/1-29-072.pdf</a>

<a id="src4" name="src4" style=" color: rgb(153, 0, 0);">New York Times 2001 (PDF)

</a><a href="http://www.wlf.org/upload/7-9-01%20NYT.pdf" style=" color: rgb(153, 0, 0); text-decoration: none;">www.wlf.org/upload/7-9-01%20NYT.pdf</a>

exxon secrets

==

Daniel J. Popeo, Chairman & General Counsel at Washington Legal Foundation (WLF), is the visionary who founded WLF in 1977. He served on the White House legal staffs of the Nixon and Ford administrations, worked in the Attorney General’s Office at the Department of Justice, and practiced as a federal trial attorney in the Honors Program of the Department of the Interior. He received his B.A. Cum Laude from Georgetown University and his J.D. from the Georgetown University Law Center.

---

<h3 class="entry-header" style="margin: 1px 0px 10px; border: 0px; color: rgb(255, 0, 0); background-color: rgb(249, 250, 232);">Daniel Popeo, Founder of the Washington Legal Foundation, Dies at 61</h3>

Daniel Popeo, the founder of the Washington Legal Foundation and a well-known advocate for businesses and free markets, died on Feb. 21, the organization announced. He was 61.

The foundation posted a notice about Popeo’s death on its website, saying he will be remembered “as a visionary leader, a tireless advocate, a compassionate colleague and a wise and generous mentor.” There were no other details immediately available.

Popeo, who served on the White House legal staffs of the Nixon and Ford administrations, started the WLF, which is generally seen as conservative, in 1977. He attracted some prominent legal minds to tackle issues that impact the free enterprise system and individual rights. The group has been zealous in filing amicus briefs across the country in business-related litigation.

“Dan was a giant in that field,” said former Attorney General Dick Thornburgh, the chairman of WLF’s Legal Policy Advisory Board. “The array of talent he could assemble on a given question was amazing.”

Thornburgh, of counsel at K&L Gates, said Popeo assembled discussion panels that had every top advocate who had argued before the U.S. Supreme Court. Popeo “spoke in no uncertain terms” when criticizing government policies in newspaper opinion pieces, but in private “he was a very self-effacing kind of guy, he was not a self promoter,” Thornburgh said.

And Popeo was persistent, persuasive and engaging. “I think he felt he had a good product to sell,” Thornburgh said. “He was a good guy.”

The WLF announcement said the organization will continue “its 34-year mission of defending free enterprise as the leading public interest law and policy center.”

Popeo worked at the Department of Justice, and practiced as a federal trial attorney in the honors program of the Department of the Interior, according to an author profile on Forbes.com.

</div>

==

WLF is to the first amendment what the NRA is to the second amendment. That is, every argument by WLF begins and ends with the first amendment as it applies to a special interest group -- i.e., businesses like the pharmaceutical industry.

<h2 class="date-header" style="margin: 0px 0px 1em; position: relative; min-height: 0px; background-color: rgb(255, 255, 255);">Tuesday, August 28, 2007</h2>

<h3 class="post-title entry-title" itemprop="name" style="color: rgb(34, 34, 34); margin: 0.75em 0px 0px; position: relative; font-weight: normal; line-height: normal; background-color: rgb(255, 255, 255);"><a id="1186214516908995943" name="1186214516908995943">"Monkeying Around" WIth The WLF</a></h3>

<a id="1186214516908995943" name="1186214516908995943" style="color: rgb(34, 34, 34); background-color: rgb(255, 255, 255);">While reading the editorial page of the New York Times yesterday, I came across </a><a href="http://home.comcast.net/_{kwbazmat/Files/WLF.htm}" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">this ad</a> which I scanned for the purposes of this post.

As you can read, the headline states, “Lawyers seek ‘victims’ for class action lawsuits,” with two unidentified well-dressed men and a whole bunch of other individuals dressed as men and women with the heads of chimps superimposed on their bodies (sorry the size of the ad is so big), implying you-know-what about the plaintiffs in these suits.

This insulting garbage is brought to us courtesy of the Washington Legal Foundation, which, as noted <a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">here</a> by SourceWatch, was established in 1977 by Chairman and General Counsel Daniel J. Popeo to "fight activist lawyers, regulators, and intrusive government agencies at the federal and state levels, in the courts and regulatory agencies across the country."

This 1998 <a href="http://www.gene.ch/gentech/1998/Jul-Sep/msg00121.html" style="color: rgb(136, 136, 136); text-decoration: none;">interview</a> with Popeo noted that the WLF, at that time, had received about $3 million in contributions from about 500 companies, though the SourceWatch article notes that, between 1985 and 2003, the group has received about $7 million in funding on top of that.

Though Popeo, in the 1998 story, apparently did not like being associated with any coalition or funding source, SourceWatch states that the WLF “sought and obtained funding from Philip Morris and the now defunct Tobacco Institute.” As a result, the WLF has also repeatedly sued government agencies that oversee public health functions, like the Food and Drug Administration and the Environmental Protection Agency, who they sued over workplace smoking policies (decrying what it calls the “junk science” of “anti-tobacco zealots”).

The WLF went after the FDA because of what the group thought was delays in allowing drugs and medical devices to market, and to show the revolving door that exists between the WLF and Bushco, <a href="http://pharmamkting.blogspot.com/2005/06/wlf-watches-fda-watching-drug-ads.html" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">this post</a> notes that Daniel E. Troy effectively landed on the WLF board after leaving Bushco’s FDA, doing his very best to hurt the agency from doing its job to ensure the safety of products under its purview (such as, in particular, Vioxx…as John Mack says, the WLF is to the First Amendment what the NRA is to the Second Amendment, with Troy as the Mike-Brown-FEMA equivalent).

Perhaps the WLF’s biggest infamy, though, is due to its attacks on Interest On Trial Lawyers Only (IOLTA) funding. As <a href="http://www.ioltanj.org/" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">this link</a> explains…

<blockquote style="background-color: rgb(255, 255, 255);">(For New Jersey) The IOLTA Fund was created by Supreme Court Rule 1:28A, and operates under the auspices of the Court, with an independent Board of Trustees. A small administrative staff handles the day-to-day management of the IOLTA program.

Very often, the amount of money that a lawyer handles for a single client is nominal in amount, to be held for a short period of time, or is the result of multiple parties or clients deciding to pool advance payments against the costs of litigation in a single fund. It would not be feasible for attorneys to establish separate interest-bearing accounts for such clients, as the cost of administering the accounts, including the lawyer's time and the bank's charges, would be greater than the amount of interest that would be generated. The Supreme Court of New Jersey permits these client deposits to be pooled in common trust accounts which are interest-bearing to IOLTA. The income is forwarded to the Fund directly by the financial institution once the IOLTA Trust Account has been established.

The money collected by IOLTA is dedicated to providing legal representation and assistance to the poor, improvements in the administration of justice, and legal education to the public. The funds can be used for no other purposes.</blockquote>

As SourceWatch continues…

<blockquote>The WLF began filing suits in a number of states to prevent IOLTA from receiving the interest on lawyer trust accounts. Among the suits was one pursued all the way to the Supreme Court of the United States with a potential recovery of $20. The reasoning behind this was outlined in a fundraising letter by the (Popeo):

"We are finally in a position we've fought more than a decade to reach...a position where we can deal a death blow to the single most important source of income for radical legal groups all across the country."

Among the foundation's adversaries in the litigation, Popeo continues, are radical left-wing groups purporting to represent the interests of the homeless, minorities, and gay and lesbian activism. In that particular instance, the WFL spent hundreds of thousands of dollars to litigate a $20 case to the Supreme Court of the United States because doing so provided it an opportunity to "deal a death blow" to a program that was inconsistent with its principles.</blockquote>

I guess one of the WLF’s principles is that people who aren’t well-moneyed or well-connected should starve, be incapacitated somehow or wronged in some other fashion and receive absolutely nothing – typical Repug garbage, of course.

<a href="http://scotus.blogspot.com/2002_12_08_scotus_archive.html#85693708" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">This link</a> contains the most recent information I can find on the case heard before the Supremes, with the supposition being that they would reaffirm a lower court ruling that the IOLTA’s use of interest on client deposits (with the interest being donated to charity) did not constitute a “taking” in violation of the Fifth Amendment (Atrios has more <a href="http://atrios.blogspot.com/2003_01_26_archive.html#390249139" style="color: rgb(136, 136, 136); text-decoration: none; background-color: rgb(255, 255, 255);">here</a> from 2003 on this, referencing some other posts linked above).

So, as far as Popeo is concerned, the WLF is ready to fight for any business against what it views as excessive governmental regulation, but it would deny that privilege in a heartbeat to anyone seeking a class-action remedy for a grievous wrong of one type or another?

This of course is typical for the WLF, which is but a tiny cog in the huge wheel of right-wing policy organizations that have operated to the detriment of the majority of this country for years and years by campaigns of misinformation and lawsuits.

At least they seemed to have failed in the IOLTA nonsense, though, since the Jersey link from which I took the earlier background information was dated in 2006. However, as Spencer Tracy so correctly stated in “Inherit The Wind,” “fanaticism and ignorance are forever busy, and need feeding” (proven by their ad yesterday).

The WLF should put that on the masthead of all of their correspondence.</div>

<div class="post-body entry-content" id="post-body-1186214516908995943" itemprop="description articleBody" style="color: rgb(34, 34, 34); width: 570px; line-height: 1.4; position: relative; background-color: rgb(255, 255, 255);"><a href="http://liberaldoomsayer.blogspot.com/2007/08/monkeying-around-with-wlf.html">http://liberaldoomsayer.blogspot.com/2007/08/monkeying-around-with-wlf.html</a></div>

</div>

===

Capital Legal Foundation

One of the many <a href="http://www.nndb.com/people/820/000043691/">Scaife</a> legal foundations. Later changed its name to the <a href="http://www.nndb.com/org/444/000050294/">Washington Legal Foundation</a>. Sued CBS on behalf of General <a href="http://www.nndb.com/people/695/000022629/">William Westmoreland</a>.

<table border="1" class="sortable" id="sort_grunk" style="background-color: rgb(255, 255, 255);"><tbody><tr class=" even"><th><a href="http://www.nndb.com/org/769/000051616/#" class="sortheader" style=" color: black; display: block;">Name</a></th><th><a href="http://www.nndb.com/org/769/000051616/#" class="sortheader" style=" color: black; display: block;">Occupation</a></th><th><a href="http://www.nndb.com/org/769/000051616/#" class="sortheader" style=" color: black; display: block;">Birth</a></th><th><a href="http://www.nndb.com/org/769/000051616/#" class="sortheader" style=" color: black; display: block;">Death</a></th><th><a href="http://www.nndb.com/org/769/000051616/#" class="sortheader" style=" color: black; display: block;">Known for</a></th></tr><tr class=" odd"><td><a href="http://www.nndb.com/people/820/000043691/">Richard Scaife</a></td><td>

<center>Activist</center>

</td><td align="right"><tt>3-Jul-1932</tt></td><td align="right"><tt> </tt></td><td>The Republican George Soros</td></tr></tbody></table>

===srcwtch

The Washington Legal Foundation (WLF) was established in 1977 to "fight activist lawyers, regulators, and intrusive government agencies at the federal and state levels, in the courts and regulatory agencies across the country" <a href="http://www.wlf.org/ataglance.asp" class="external autonumber" title="http://www.wlf.org/ataglance.asp" rel="nofollow">[1]</a>. WLF is classified as a national, non-profit, tax-exempt public foundation under section <a href="http://www.sourcewatch.org/index.php?title=501%28c%29%283%29" title="501(c)(3)">501(c)(3)</a> of the Internal Revenue Code.

<h2>Contents</h2>

</div>

<ul>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Mission">1 Mission</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Income_Statement_.28FYE_12.2F2007.29">2 Income Statement (FYE 12/2007)</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Funding">3 Funding</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#WLF_and_Tobacco">4 WLF and Tobacco</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Attacking_IOLTA_legal_assistance">5 Attacking IOLTA legal assistance</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Contact_information">6 Contact information</a></li>

<li class="toclevel-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Articles_and_Resources">7 Articles and Resources</a>

<ul>

<li class="toclevel-2"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Sources">7.1 Sources</a></li>

<li class="toclevel-2"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#Related_SourceWatch_Articles">7.2 Related SourceWatch Articles</a></li>

<li class="toclevel-2"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#External_Articles">7.3 External Articles</a></li>

</ul>

</li>

</ul>

</td></tr></tbody></table>

<h2 style="background-color: rgb(255, 255, 255);">Mission</h2>

The foundation states that it has "one goal" which is:

<dd>"to defend and promote the principles of freedom and justice." Since it was founded 25 years ago, WLF has developed into the nation's preeminent center for public interest law, advocating free-enterprise principles, responsible government, property rights, a strong national security and defense, and balanced civil and criminal justice system.</dd>

</dl>

<h2 style="background-color: rgb(255, 255, 255);">Income Statement (FYE 12/2007)</h2>

Total Revenue $5,315,75

<dd>WLF is a unique institution with three essential cornerstone programs:</dd>

</dl>

<dl>

<dd>

<ul>

<li style=" background-color: rgb(255, 255, 255);">shaping public policy through aggressive litigation and advocacy</li>

<li>publishing timely legal studies</li>

<li>educating policy-makers and the public through extensive communications outreach</li>

</ul>

</dd>

</dl>

<dd>[...] With this unique approach, litigating precedent-setting issues in the courts and before government agencies, publishing and marketing timely and relevant legal studies, and ensuring maximum exposure for its work with policy-makers and the media, the Washington Legal Foundation is able to shape public policy and work with allies in government and our legal system to strengthen America's free enterprise system."<a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#cite_note-0" title="">[1]</a></dd>

</dl>

<h2 style="background-color: rgb(255, 255, 255);">Funding</h2>

The foundation has received donations from the tobacco industry and has run quarter-page ads in the <a href="http://www.sourcewatch.org/index.php?title=New_York_Times" title="New York Times">New York Times</a>, opposing what it calls "<a href="http://www.sourcewatch.org/index.php?title=Junk_science" title="Junk science">junk science</a>."

Media Transparency report that between 1985 and 2005 WLF have received 73 grants totalling $8,356,000<a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#cite_note-1" title="">[2]</a>

EIN: 52-1071570 Washington Legal Foundation (unadjusted for inflation) from a range of foundations including:

<li><a href="http://www.sourcewatch.org/index.php?title=Rodney_Fund" title="Rodney Fund">Rodney Fund</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=F.M._Kirby_Foundation" title="F.M. Kirby Foundation">F.M. Kirby Foundation</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=Lynde_%26_Harry_Bradley_Foundation" title="Lynde & Harry Bradley Foundation" class="mw-redirect">Lynde & Harry Bradley Foundation</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=The_Carthage_Foundation&action=edit&redlink=1" class="new" title="The Carthage Foundation (page does not exist)">The Carthage Foundation</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=John_M._Olin_Foundation" title="John M. Olin Foundation">John M. Olin Foundation</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=Claude_R._Lambe_Foundation" title="Claude R. Lambe Foundation" class="mw-redirect">Claude R. Lambe Foundation</a></li>

<li><a href="http://www.sourcewatch.org/index.php?title=Sarah_Scaife_Foundation" title="Sarah Scaife Foundation" class="mw-redirect">Sarah Scaife Foundation</a></li>

</ul>

<h2 style="background-color: rgb(255, 255, 255);">WLF and Tobacco</h2>

Internal tobacco industry documents also reveal that WLF sought and obtained funding from <a href="http://www.sourcewatch.org/index.php?title=Philip_Morris" title="Philip Morris" class="mw-redirect">Philip Morris</a> and the now defunct <a href="http://www.sourcewatch.org/index.php?title=Tobacco_Institute" title="Tobacco Institute">Tobacco Institute</a>. From documents available to date the funding includes:

<li><a href="http://www.sourcewatch.org/index.php?title=Philip_Morris" title="Philip Morris" class="mw-redirect">Philip Morris</a>

<ul>

<li>1999: $200,000 (budgeted) <a href="http://www.pmdocs.com/getimg.asp?DOCID=2073204303/4305&PGNO=2073204305" class="external autonumber" title="http://www.pmdocs.com/getimg.asp?DOCID=2073204303/4305&PGNO=2073204305" rel="nofollow">[6]</a></li>

</ul>

</li>

<li>The <a href="http://www.sourcewatch.org/index.php?title=Tobacco_Institute" title="Tobacco Institute">Tobacco Institute</a>

<ul>

<li>

</li></ul>

</li>

</ul>

In 1994, Wisconsin Governor <a href="http://www.sourcewatch.org/index.php?title=Tommy_Thompson" title="Tommy Thompson">Tommy Thompson</a> (who preceded <a href="http://www.sourcewatch.org/index.php?title=Mike_Leavitt" title="Mike Leavitt" class="mw-redirect">Mike Leavitt</a> as head of the <a href="http://www.sourcewatch.org/index.php?title=U.S._Department_of_Health_and_Human_Services" title="U.S. Department of Health and Human Services" class="mw-redirect">U.S. Department of Health and Human Services</a>, which oversees the tobacco control functions of federal government) joined the policy advisory board of the Washington Legal Foundation. WLF, which receives funding from the Philip Morris tobacco company (PM), publicly defends the tobacco industry. In 1998, the WLF ran an inflammatory, pro-tobacco advertisement titled "In all Fairness: A Constitutional tragedy in the making" in several large papers including the New York Times, the Washington Post, the National Journal, the CongressDaily AM, and others. Easily recongizeable in the article are many of the tobacco industry's arguments (freedom of speech, the Bill of Rights, "slippery slope" arguments about enacting "prohibition" as well as emotion-laden phrases like "anti-tobacco zealots").<a href="http://legacy.library.ucsf.edu/tid/hsc13e00" class="external autonumber" title="http://legacy.library.ucsf.edu/tid/hsc13e00" rel="nofollow">[11]</a>

In addition to running this type of ad, the WLF has also repeatedly sued government agencies that oversee public health functions, like the Food and Drug Administration and the Enivronmental Protection Agency, who they sued over workplace smoking policies.

An April 1994 activity report by Philip Morris employee <a href="http://www.sourcewatch.org/index.php?title=Roy_E._Marden" title="Roy E. Marden" class="mw-redirect">Roy E. Marden</a> states he was "Working with the Washington Legal Foundation (WLF)in the development of a strategy to counteract and attack the efforts of the antis [public health advocates]..."<a href="http://legacy.library.ucsf.edu/tid/hrs75c00" class="external autonumber" title="http://legacy.library.ucsf.edu/tid/hrs75c00" rel="nofollow">[12]</a>

WLF was listed as a think tank housing "policy analysts sympathetic with our views" in a February 25, 1999 memo from <a href="http://www.sourcewatch.org/index.php?title=BSMG_Worldwide" title="BSMG Worldwide">BSMG Worldwide</a> to Philip Morris describing strategies to "support a full court press to thwart the filing of a federal lawsuit against the tobacco industry in order to force the industry to settlement." The objective of the strategy was to "[Enlist] allies and other potential third parties to help provide a "echo chamber" of opinion in local, regional,and national media, consistent with our messages.<a href="http://legacy.library.ucsf.edu/tid/iug62c00" class="external autonumber" title="http://legacy.library.ucsf.edu/tid/iug62c00" rel="nofollow">[13]</a>

<h2 style="background-color: rgb(255, 255, 255);">Attacking IOLTA legal assistance</h2>

Interest On Lawyers' Trust Accounts (IOLTA) legislation is enacted in almost all US states and allows the interest on money held by lawyers on behalf of a third party to go to good causes. The system generated over $148 million dollars in 2002, the funds being used to assist poor people in obtaining legal representation.

The WLF began filing suits in a number of states to prevent IOLTA from receiving the interest on lawyer trust accounts. Among the suits was one persued all the way to the Supreme Court of the United States with a potential recovery of $20. The reasoning behind this was outlined in a <a href="http://www.sourcewatch.org/index.php?title=Fundraising&action=edit&redlink=1" class="new" title="Fundraising (page does not exist)">fundraising</a> letter by the WLF Chairman <a href="http://www.sourcewatch.org/index.php?title=Daniel_Popeo" title="Daniel Popeo">Daniel Popeo</a>:

<dd>"We are finally in a position we've fought more than a decade to reach...a position where we can deal a death blow to the single most important source of income for radical legal groups all across the country"</dd>

</dl>

Among the foundation's adversaries in the litigation, Popeo continues, are radical left-wing groups purporting to represent the interests of the homeless, minorities, and gay and lesbian activism. In that particular instance, the WFL spent hundreds of thousands of dollars to litigate a $20 case to the Supreme Court of the United States because doing so provided it an opportunity to "deal a death blow" to a program that was inconsistent with its principles.

<h2 style="background-color: rgb(255, 255, 255);">Contact information</h2>

Washington Legal Foundation

2009 Massachusetts Ave., NW

Washington, DC 20036

Phone: 202-588-0302

Email: info AT wlf.org

WebL <a href="http://www.wlf.org/" class="external free" title="http://www.wlf.org/" rel="nofollow">http://www.wlf.org/</a>

<h2 style="background-color: rgb(255, 255, 255);">Articles and Resources</h2>

<h3 style="background-color: rgb(255, 255, 255);">Sources</h3>

<li id="cite_note-0"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#cite_ref-0" title="">↑</a> <a href="http://www.wlf.org/Resources/WLFMission/" class="external text" title="http://www.wlf.org/Resources/WLFMission/" rel="nofollow">"Resources: WLF Mission"</a>, accessed December 2007.</li>

<li id="cite_note-1"><a href="http://www.sourcewatch.org/index.php?title=Washington_Legal_Foundation#cite_ref-1" title="">↑</a> <a href="http://www.mediatransparency.org/recipientgrants.php?recipientID=912" class="external text" title="http://www.mediatransparency.org/recipientgrants.php?recipientID=912" rel="nofollow">"Recipient Grants: Washington Legal Foundation"</a>, accessed December 2007.</li>

</ol>

<h3 style="background-color: rgb(255, 255, 255);">Related SourceWatch Articles</h3>

<h3 style="background-color: rgb(255, 255, 255);">External Articles</h3>

<li>Media Transparency, <a href="http://www.mediatransparency.org/recipientprofile.php?recipientID=912" class="external text" title="http://www.mediatransparency.org/recipientprofile.php?recipientID=912" rel="nofollow">Washington Legal Foundation</a></li>

<li>P.L.A. - A Journal of Politics, Law and Autism, <a href="http://pla.blogspot.com/2003_01_26_pla_archive.html#88198368" class="external text" title="http://pla.blogspot.com/2003_01_26_pla_archive.html#88198368" rel="nofollow">"The Outrageous Washington Legal Foundation"</a></li>

</ul>

This article may include <a href="http://tobaccodocuments.org/profiles/people/wlf.html" class="external text" title="http://tobaccodocuments.org/profiles/people/wlf.html" rel="nofollow">information from Tobacco Documents Online</a>.

---

seems to get a lot of coverage on RW? blog: <a href="http://lawprofessors.typepad.com/whitecollarcrime_blog/environment/">http://lawprofessors.typepad.com/whitecollarcrime_blog/environment/</a>

501(c)(3) nonprofit

Employer Identification Number: 52-1071570

The Washington Legal Foundation is a nonprofit legal organization. Founded in 1977, it advocates for free market principles, limited and accountable government, individual rights, business civil liberties, and legal ethics. It carries out its mission through publishing, litigation, and outreach programs.

The Washington Legal Foundation has received significant funding from the tobacco industry, as well as Bradley, Olin, and Scaife foundations. Former and current board members include former Attorney General John Ashcroft, former Sen. George Allen (R-VA), Gov. Haley Barbour (R-MI), and Kenneth Starr.

<a href="http://mediamattersaction.org/transparency/organization/Washington_Legal_Foundation">http://mediamattersaction.org/transparency/organization/Washington_Legal_Foundation</a>

</div>

==

<div style="text-align: left;">FREEDOM HOLDINGS, INC., d/b/a North American Trading Co. and International Tobacco Partners, Ltd., on behalf of themselves and all others similarly situated, Plaintiffs-Appellants,</div>

<div style="text-align: left;">Eliot SPITZER, in his official capacity as Attorney General of the State of New York and Arthur J. Roth, in his official capacity as Commissioner of Taxation and Finance of the State of New York, Defendants-Appellees.</div>

<div style="text-align: left;">Docket No. 04-4996-CV.</div>

<p class="court" style="text-align: left; margin: 0px 0px 20px; padding: 0px; border: 0px; border-image-source: initial; border-image-slice: initial; border-image-width: initial; border-image-outset: initial; border-image-repeat: initial; outline: 0px; vertical-align: baseline; line-height: 20px; font-weight: bold; background-color: rgb(255, 255, 255);">United States Court of Appeals, Second Circuit.

Argued: February 1, 2005.

Decided: May 18, 2005.

---

Richard Samp is Chief Counsel of the Washington Legal Foundation, a nonprofit public interest law firm located in Washington, D.C. WLF litigates in support of individual rights and the free-enterprise system and against excessive government regulation. Samp has been with WLF since 1989. He practices regularly before the U.S. Supreme Court and other federal courts, with a speciality in health care law. He regularly represents patients seeking to obtain health care without undue interference from the federal government and filed an amicus curiae brief in Peake v. Sanders in support of the Respondents, on behalf of a coalition of veterans groups.

Samp is a graduate of Harvard College and the University of Michigan Law School. Before joining WLF, he clerked for a unnamed] federal judge in Michigan and was a litigator at the Washington, D.C., law firm of Shaw Pittman.

Education

<div class="authorContent" style="margin: 0px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;">A.B., Harvard College

J.D., University of Michigan</div>

Publications

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/restraining-park-doctrine-prosecutions-against-corporate-officials-under-the-fdca" style=" margin: 0px; padding: 0px; text-decoration: none;">Restraining Park Doctrine Prosecutions Against Corporate Officials Under the FDCA</a>

Engage Volume 13, Issue 3 October 2012

February 1, 2013</div>

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/touching-on-the-merits-when-deciding-class-certification-motions-ohios-experience" style=" margin: 0px; padding: 0px; color: rgb(62, 85, 172); text-decoration: none;">Touching on the Merits When Deciding Class Certification Motions: Ohio's Experience</a>

Class Action Watch Volume 11, Issue 1

May 30, 2012</div>

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/ashcroft-v-al-kidd-post-decision-scotuscast" style=" margin: 0px; padding: 0px; color: rgb(62, 85, 172); text-decoration: none;">Ashcroft v. al-Kidd - Post-Decision SCOTUScast</a>

SCOTUScast 07-20-11 featuring Richard A. Samp

July 20, 2011</div>

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/graham-county-soil-water-conservation-district-v-united-states-ex-rel-wilson-post-decision-scotuscast" style=" margin: 0px; padding: 0px; color: rgb(62, 85, 172); text-decoration: none;">Graham County Soil & Water Conservation District v. United States ex rel. Wilson - Post-Decision SCOTUScast</a>

SCOTUScast 08-04-10 featuring Richard A. Samp

August 4, 2010</div>

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/scotuscast-3-13-09-featuring-richard-samp" style=" margin: 0px; padding: 0px; color: rgb(62, 85, 172); text-decoration: none;">SCOTUScast 3-13-09 featuring Richard Samp</a>

Peake v. Sanders

March 13, 2009</div>

<div class="authorItem" style="margin: 0px 0px 5px; padding: 2px 0px 0px; color: rgb(51, 51, 51); line-height: normal;"><a href="http://www.fed-soc.org/publications/detail/speech-and-privacy-regulation-in-the-world-of-drugs-and-healthcare" style=" margin: 0px; padding: 0px; color: rgb(62, 85, 172); text-decoration: none;">Speech and Privacy Regulation in the World of Drugs and Healthcare</a>

October 1, 2002</div>

<p class="date" style="text-align: left; margin: 0px 0px 20px; padding: 0px; border: 0px; border-image-source: initial; border-image-slice: initial; border-image-width: initial; border-image-outset: initial; border-image-repeat: initial; outline: 0px; vertical-align: baseline; line-height: 20px; background-color: rgb(255, 255, 255);">===

</div>

Wash Legal Fdn WLF

Attachments